Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches
Table 1
Summary of the clinical data for patients genomically profiled in this study (n = 41). Patients with IDH-wildtype and IDH-mutant glioblastoma tumours were identified from the BRASH clinical database between 2009 and 2014.